NASDAQ:HRMY | Free Cash Flow | Harmony Biosciences Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$27.76M
2025-12-31$126.15M$107,000.00$126.04M560.54%
2025-03-31$33.99M$128,000.00$33.86M74.32%
2024-12-31$75.56M$513,000.00$75.05M151.69%
2024-03-31$31.14M$5,000.00$31.14M81.22%
2023-12-31$76.67M$107,000.00$76.56M287.74%
2023-03-31$42.56M
2022-12-31$26.68M$0.00$26.68M55.00%
2022-03-31$28.85M$45,000.00$28.81M134.08%
2021-12-31$37.53M$0.00$37.53M165.24%
2021-03-31$12.53M$4,000.00$12.53M169.59%
2020-12-31$10.05M$0.00$10.05M
2020-03-31-$26.7M
2019-12-31-$23.99M$36,000.00-$24.02M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$348.2M$310,000.00$347.89M219.23%
2024-12-31$219.82M$1.15M$218.67M150.29%
2023-12-31$219.39M$312,000.00$219.08M170.02%
2022-12-31$144.47M$172,000.00$144.29M79.51%
2021-12-31$98.56M$298,000.00$98.26M284.01%
2020-12-31-$2.99M$2,000.00-$2.99M
2019-12-31-$75.44M$149,000.00-$75.59M